<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

A Look Back: The One to Beat, Nevro's Growth Strategies and Challenges

Posted by Anne Staylor on 6/18/18 4:37 PM

In May 2017, Nevro CEO Rami Elghandour chatted with Anne Staylor, BioMedGPS Managing Editor/Neuro Analyst to discuss dynamics in the global spinal cord stimulation (SCS) market, including trends, drivers, challenges, competition, and opportunity that would influence the Company’s growth. 

A fascinating read then, that now has us appraising a year later if Elghandour's expansion predictions came to pass. Is Nevro still the one to beat as the top leader in the neuromodulation field?

Register to download PDF or read the interview in full below!

Read More

Topics: Neuromodulation, Neurotherapies, Neuromodulation-Spinal Cord Stimulation

SmartTRAK Attending LINNC Paris 2018

Posted by Anne Staylor on 6/4/18 6:34 PM

SmartTRAK is excited to be attending LINNC Paris 2018 on June 11-13, 2018, at the Carrousel du Louvre, Paris, France.

Attending the meeting representing  SmartTRAK  will be  Anne Staylor , Managing Editor, Business Intelligence and Senior Director, Advanced Technologies.
Read More

Topics: Neurotherapies, SmartTRAK Conferences

Nevro’s Growth Strategies and Challenges in the Spinal Cord Stimulation Market

Posted by Anne Staylor on 5/29/17 3:50 PM

Nevro:  The One to Beat!

In an interview with BioMedGPS, Nevro CEO Rami Elghandour discussed the Company’s success, its growth strategies, and some of the challenges of being the one to beat in the spinal cord stimulation (SCS) market.

Since disrupting the market with its paresthesia-free high frequency (HF10) Senza SCS System, Nevro has set a new standard of care for SCS with unparalleled clinical evidence and success in treating chronic intractable leg and back pain.

Read More

Topics: Neurotherapies

#INS2017 Exhibit Hall is Open!

Posted by Rebecca Gonzalez on 5/29/17 3:33 PM

And Anne Staylor is off and running!

Meet with Anne Staylor at #INS2017, Senior SmartTRAK Analyst and Managing Editor, and get your questions answered about SmartTRAK and Neuro Therapies business, market and competitive intelligence. 

Meet with Anne Staylor at INS 2017

Read More

Topics: Neurotherapies

SmartTRAK's Neuro Analyst, Anne Staylor, to Attend INS 2017

Posted by Rebecca Gonzalez on 5/25/17 3:18 PM

 SmartTRAK will be at the International Neuromodulation Society 13th World Congress “Neuromodulation: Technology Changing Lives” in Edinburgh, Scotland May 27- June 1. Meet with Anne Staylor, Senior SmartTRAK Analyst and Managing Editor!

Meet with Anne Staylor at INS 2017

Read More

Topics: Neuromodulation, Neurotherapies

Nuvectra: Positioned For Growth In Neuromodulation

Posted by Anne Staylor on 5/4/17 2:00 PM

It’s been less than a year since Nuvectra Medical spun-off from Greatbatch Inc. (now Integer), and in that time Nuvectra has built a sales organization and laid the organizational foundation to become a, multi-indication neurostimulation company.

Read More

Topics: Neuromodulation, Neurotherapies

BioMedGPS Announces Expansion of SmartTRAK Business Intelligence to the Neuromodulation and Neurovascular Markets

Posted by Anne Staylor on 1/25/17 5:46 PM

January 25, 2017 02:46 PM Eastern Standard Time

IRVINE, Calif.--()--BioMedGPS, the leading provider of real-time business analytics and analysis of the orthopedic/spine, wound care and regenerative medicine markets, announces expanded coverage of SmartTRAK Business Intelligence to the Neuro Therapies market with the introduction of SmartTRAK Neuromodulation and SmartTRAK Neurovascularmodules.

Read More

Topics: Neurotherapies

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts